Vertex Pharmaceuticals
American biopharmaceutical company

Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. Founded in 1989 by Joshua Boger and Kevin J. Kinsella, Vertex is known for its focus on developing small molecule drugs for the treatment of serious diseases.
History[edit]
Vertex Pharmaceuticals was established in 1989 in Cambridge, Massachusetts. The company was founded by Joshua Boger, a former Merck executive, and Kevin J. Kinsella, a venture capitalist. Vertex was one of the first biotechnology firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Research and Development[edit]
Vertex is renowned for its research and development in the field of cystic fibrosis (CF). The company has developed several breakthrough therapies for CF, including ivacaftor, lumacaftor, and tezacaftor. These drugs target the underlying causes of CF, providing significant improvements in lung function and quality of life for patients.
Products[edit]
Vertex's product portfolio includes several approved drugs, primarily focused on cystic fibrosis. The company's flagship product, ivacaftor, was the first drug to treat the underlying cause of CF in patients with specific mutations. Other notable products include lumacaftor/ivacaftor and tezacaftor/ivacaftor.
Pipeline[edit]
Vertex continues to invest heavily in its research pipeline, exploring treatments for other serious diseases such as sickle cell disease, beta thalassemia, and pain management. The company is also investigating the use of gene editing technologies, such as CRISPR, in collaboration with other biotech firms.
Corporate Structure[edit]
Vertex Pharmaceuticals is headquartered in Boston, Massachusetts, with additional research facilities in San Diego, California, and Oxford, England. The company is publicly traded on the NASDAQ under the ticker symbol VRTX.
Community Engagement[edit]
Vertex is committed to community engagement and corporate social responsibility. The company supports various initiatives aimed at improving science education and increasing access to healthcare.
Related pages[edit]
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99 with insurance
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian